27.09.2022 - REVERSE-HF will evaluate ultrafiltration therapy in comparison to IV diuretics to treat heart failure patients with fluid overloadMINNEAPOLIS, Sept. 27, 2022 (GLOBE NEWSWIRE) - Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage company focused on . Seite 1